Blocked and nonblocked acid secretion and reported pain in ulcer, nonulcer dyspepsia, and normal subjects.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 2744356)

Published in Gastroenterology on August 01, 1989

Authors

S Bates1, P O Sjödén, J Fellenius, O Nyrén

Author Affiliations

1: Department of Clinical Psychology, University Hospital, Uppsala University, Sweden.

Articles by these authors

Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med (1999) 17.30

The risk of stomach cancer in patients with gastric or duodenal ulcer disease. N Engl J Med (1996) 4.81

Randomized comparison between chemotherapy plus best supportive care with best supportive care in advanced gastric cancer. Ann Oncol (1997) 4.69

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer. Ann Oncol (1996) 4.00

Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology (1995) 3.86

Association between body mass and adenocarcinoma of the esophagus and gastric cardia. Ann Intern Med (1999) 3.31

Acetaminophen, aspirin, and chronic renal failure. N Engl J Med (2001) 3.28

Helicobacter pylori infection in Swedish school children: lack of evidence of child-to-child transmission outside the family. Gastroenterology (2001) 3.17

Evaluating gastric cancer misclassification: a potential explanation for the rise in cardia cancer incidence. J Natl Cancer Inst (1999) 3.13

A prospective study of obesity and cancer risk (Sweden). Cancer Causes Control (2001) 3.13

Excess risk of primary liver cancer in patients with diabetes mellitus. J Natl Cancer Inst (1996) 2.78

Drug treatment of functional dyspepsia: a systematic analysis of trial methodology with recommendations for design of future trials. Am J Gastroenterol (1996) 2.73

Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology (1993) 2.64

The role of tobacco, snuff and alcohol use in the aetiology of cancer of the oesophagus and gastric cardia. Int J Cancer (2000) 2.58

Rapid healing of duodenal ulcers with omeprazole: double-blind dose-comparative trial. Lancet (1983) 2.51

Risk of adenocarcinomas of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery. Gastroenterology (2001) 2.34

Inverse association between intake of cereal fiber and risk of gastric cardia cancer. Gastroenterology (2001) 2.30

Patient and staff perceptions of cancer patients' psychological concerns and needs. Acta Oncol (2000) 2.23

AGA technical review: evaluation of dyspepsia. American Gastroenterological Association. Gastroenterology (1998) 2.19

No relation between body mass and gastro-oesophageal reflux symptoms in a Swedish population based study. Gut (2000) 2.16

Venous thromboembolism and cancer. Lancet (1998) 2.08

Risk of urinary tract cancers following kidney or ureter stones. J Natl Cancer Inst (1997) 2.06

Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancer. Ann Oncol (1995) 2.01

No survival benefit from early-start dialysis in a population-based, inception cohort study of Swedish patients with chronic kidney disease. J Intern Med (2010) 2.01

Body size and prostate cancer: a 20-year follow-up study among 135006 Swedish construction workers. J Natl Cancer Inst (1997) 1.98

Sunlight and non-Hodgkin's lymphoma: a population-based cohort study in Sweden. Int J Cancer (1999) 1.97

Initial or delayed chemotherapy with best supportive care in advanced gastric cancer. Ann Oncol (1994) 1.96

Helicobacter pylori in gastric cancer established by CagA immunoblot as a marker of past infection. Gastroenterology (2001) 1.87

Association between medications that relax the lower esophageal sphincter and risk for esophageal adenocarcinoma. Ann Intern Med (2000) 1.83

Absence of therapeutic benefit from antacids or cimetidine in non-ulcer dyspepsia. N Engl J Med (1986) 1.79

Risk factors for oesophageal cancer in northeast China. Int J Cancer (1994) 1.73

Diabetes mellitus and risk of large bowel cancer. J Natl Cancer Inst (1997) 1.68

Risk of pancreatic cancer following diabetes mellitus: a nationwide cohort study in Sweden. J Natl Cancer Inst (1995) 1.62

Self-esteem, depression and anxiety among Swedish children and adolescents on and off cancer treatment. Acta Paediatr (2000) 1.59

Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer (1993) 1.57

Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer (1991) 1.56

Quality of life during chemotherapy in patients with symptomatic advanced colorectal cancer. The Nordic Gastrointestinal Tumor Adjuvant Therapy Group. Cancer (1994) 1.54

The risk of esophageal cancer in patients with achalasia. A population-based study. JAMA (1995) 1.51

Pancreatitis and pancreatic cancer: a population-based study. J Natl Cancer Inst (1994) 1.49

Does the method of Helicobacter pylori detection influence the association with gastric cancer risk? Scand J Gastroenterol (2002) 1.46

The role of diabetes mellitus in the aetiology of renal cell cancer. Diabetologia (1999) 1.45

Lifestyle and endometrial cancer risk: a cohort study from the Swedish Twin Registry. Int J Cancer (1999) 1.44

Risk of endometrial and breast cancer in patients with diabetes mellitus. Int J Cancer (1997) 1.42

Increasing incidence of carcinoma of the gastric cardia in Sweden from 1970 to 1985. Br J Surg (1993) 1.40

Do sex hormones play a role in the etiology of esophageal adenocarcinoma? A new hypothesis tested in a population-based cohort of prostate cancer patients. Cancer Epidemiol Biomarkers Prev (1998) 1.38

Alcohol abuse and the risk of pancreatic cancer. Gut (2002) 1.35

Reproducibility and validity of a postal questionnaire. The abdominal symptom study. Scand J Prim Health Care (1993) 1.35

The risk of pancreatic cancer following pancreatitis: an association due to confounding? Gastroenterology (1997) 1.34

Tobacco, alcohol and the risk of gastric cancer by sub-site and histologic type. Int J Cancer (1999) 1.33

Fruit and vegetable consumption in the prevention of oesophageal and cardia cancers. Eur J Cancer Prev (2001) 1.31

Short- and long-term anxiety and depression in women recalled after breast cancer screening. Eur J Cancer (2001) 1.29

Aspirin and risk for gastric cancer: a population-based case-control study in Sweden. Br J Cancer (2001) 1.26

The risk of gastrointestinal and other primary malignant diseases following gastric cancer. Acta Oncol (1991) 1.26

Nutrients and gastric cancer risk. A population-based case-control study in Sweden. Int J Cancer (1994) 1.25

Risk of cancers of the oesophagus and stomach by histology or subsite in patients hospitalised for pernicious anaemia. Gut (2003) 1.25

Incidence of cancer among patients with systemic sclerosis. Cancer (1995) 1.25

Helicobacter pylori strain types and risk of gastric cancer: a case-control study. Cancer Epidemiol Biomarkers Prev (2000) 1.24

Reflux-inducing dietary factors and risk of adenocarcinoma of the esophagus and gastric cardia. Nutr Cancer (2000) 1.23

Appendectomy in Sweden 1989-1993 assessed by the Inpatient Registry. J Clin Epidemiol (1998) 1.22

The epidemiology of abdominal symptoms: prevalence and demographic characteristics in a Swedish adult population. A report from the Abdominal Symptom Study. Scand J Gastroenterol (1994) 1.22

Survival in stomach cancer is improving: results of a nationwide population-based Swedish study. Ann Surg (1999) 1.22

Nationwide study of cancer risk among hip replacement patients in Sweden. J Natl Cancer Inst (2001) 1.19

Dietary antioxidant intake and the risk of cardia cancer and noncardia cancer of the intestinal and diffuse types: a population-based case-control study in Sweden. Int J Cancer (2000) 1.18

Early-life risk indicators of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1994) 1.17

A population-based binational register for monitoring long-term outcome and possible disease concordance among blood donors and recipients. Vox Sang (2006) 1.17

Post-transfusion mortality among recipients of ABO-compatible but non-identical plasma. Vox Sang (2009) 1.16

'Satisfaction with care': associations with health-related quality of life and psychosocial function among Swedish patients with endocrine gastrointestinal tumours. Eur J Cancer Care (Engl) (2002) 1.16

Validation of an Inguinal Pain Questionnaire for assessment of chronic pain after groin hernia repair. Br J Surg (2008) 1.13

Predicting anxiety and depression among cancer patients: a clinical model. Eur J Cancer (2001) 1.13

Colorectal cancer after cholecystectomy: absence of risk increase within 11-14 years. Gastroenterology (1983) 1.12

Human papillomavirus infection and esophageal cancer: a nationwide seroepidemiologic case-control study in Sweden. J Natl Cancer Inst (1999) 1.11

Quality of life of cancer patients and their spouses in palliative home care. Palliat Med (1998) 1.11

Antioxidants and cancers of the esophagus and gastric cardia. Int J Cancer (2000) 1.11

General condition of asymptomatic patients with advanced colorectal cancer receiving palliative chemotherapy. A longitudinal study. Acta Oncol (1992) 1.10

The clinical diagnosis of 'gastritis'. Aspects of demographic epidemiology and health care consumption based on a nationwide sample survey. Scand J Gastroenterol (1984) 1.08

One stomach--one strain: does Helicobacter pylori strain variation influence disease outcome? Dig Dis Sci (1999) 1.07

Prevalence of Helicobacter pylori infection in subtypes of gastric cancer. Gastroenterology (1995) 1.07

Effect of endocrine treatment on sexuality in premenopausal breast cancer patients: a prospective randomized study. J Clin Oncol (2001) 1.06

Cancer patient and staff ratings of the importance of caring behaviors and their relations to patient anxiety and depression. J Adv Nurs (1998) 1.06

The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis. Hepatology (2001) 1.04

Group rehabilitation for cancer patients: satisfaction and perceived benefits. Patient Educ Couns (2000) 1.03

Smoking and the risk of leukemia, lymphoma, and multiple myeloma (Sweden). Cancer Causes Control (1998) 1.03

Quality of life during cytostatic therapy for advanced symptomatic colorectal carcinoma: a randomized comparison of two regimens. Eur J Cancer Clin Oncol (1989) 1.03

Primary brain tumors following traumatic brain injury--a population-based cohort study in Sweden. Cancer Causes Control (2001) 1.03

Social and economic effects of non-ulcer dyspepsia. Scand J Gastroenterol Suppl (1985) 1.02

Occupational physical activity and risk for breast cancer in a nationwide cohort study in Sweden. Cancer Causes Control (1999) 1.01

Breast cancer risk and lifetime leisure-time and occupational physical activity (Sweden). Cancer Causes Control (2000) 1.01

Incidence of cancer among patients with hidradenitis suppurativa. Arch Dermatol (2001) 1.01

Breast cancer following breast reduction surgery in Sweden. Plast Reconstr Surg (2000) 1.00

Incidence of lung cancer in a large cohort of non-smoking men from Sweden. Int J Cancer (2001) 1.00

Oral status during radiotherapy and chemotherapy: a descriptive study of patient experiences and the occurrence of oral complications. Support Care Cancer (2001) 1.00

Assessment of sun-related behaviour in individuals with dysplastic naevus syndrome: a comparison between diary recordings and questionnaire responses. Melanoma Res (1997) 1.00

Cause-specific mortality in a cohort of patients with diabetes mellitus: a population-based study in Sweden. J Clin Epidemiol (2001) 0.99

The "epigastric distress syndrome". A possible disease entity identified by history and endoscopy in patients with nonulcer dyspepsia. J Clin Gastroenterol (1987) 0.99

Tobacco, alcohol and the risk of gastric cancer. A population-based case-control study in Sweden. Int J Cancer (1994) 0.99

Effects of information supply on satisfaction with information and quality of life in cancer patients receiving curative radiation therapy. Patient Educ Couns (2001) 0.99

A prospective study of smoking and risk of prostate cancer. Int J Cancer (1996) 0.98

Heredity and risk of cancer of the esophagus and gastric cardia. Cancer Epidemiol Biomarkers Prev (2000) 0.97